Repurposing liraglutide to the management of DSS-induced colitis: a potential for promoting autophagy
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-12 · 398 (12) · 17173-17185
DOI: 10.1007/s00210-025-04339-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 05.06.2025. Verfasst von Ahmed Atef Saadoun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura Manchester Medical Program, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt. Hauptthemen laut MEDLINE: Liraglutide, Autophagy, Colitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mansoura Manchester Programme for Medical Education (MMPME), Faculty of Medicine, Mansoura University, Egypt, Mansoura University.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that typically requires long-term drug treatment. The emerging role of glucagon-like peptide 1 (GLP-1) and its receptor agonists in gastrointestinal diseases has drawn much attention. A mouse model of acute colitis was conducted using a 7-day protocol of dextran sulfate sodium (DSS, 3% w/v in drinking water) administration. The efficacy of liraglutide (a GLP-1 receptor agonist) in treating DSS-induced colitis and its accompanying Paneth cell metaplasia was examined and correlated to its impact on the levels of colonic autophagy. Liraglutide effectively ameliorated colitis symptoms in mice. Dose-dependent improvements in disease activity index (DAI), colon length, and histopathological scores of inflammation and mucosal damage were evident in the liraglutide-treated groups compared to the DSS group. In addition, liraglutide reduced the expression of lysozyme and suppressed colonic Paneth cell metaplasia induced by DSS. Notably, liraglutide also enhanced levels of colonic autophagy. Direct visualization of autophagosomes and autolysosomes under an electron microscope along with p62 accumulation following co-treatment with chloroquine supports the role of liraglutide as an autophagy enhancer. Liraglutide ameliorated DSS-induced colitis and prevented Paneth cell metaplasia possibly via enhancing colonic autophagy. Our findings strongly signify liraglutide as a therapeutic option for UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mansoura Manchester Medical Program, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
- Program of Medicine, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
- Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
- Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
- Medical Experimental Research Center (MERC), Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt. nehalpharma@mans.edu.eg.
- Clinical Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt. nehalpharma@mans.edu.eg.
Förderung
- Mansoura Manchester Programme for Medical Education (MMPME), Faculty of Medicine, Mansoura University, Egypt
- Mansoura University
Zitieren
APA
Saadoun, A. A., Abdelsattar, A. H., Elsaid, A. H., Abdelaleam, E. A., Abdelkader, H. K., Ibrahim, H. M., Saad, M. S., Ellawi, M. S., Elsaid, R. E., Maghrabia, A., Ibrahim, D., & Ramadan, N. M. (2025). Repurposing liraglutide to the management of DSS-induced colitis: a potential for promoting autophagy. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(12), 17173-17185. https://doi.org/10.1007/s00210-025-04339-w
Vancouver
Saadoun AA, Abdelsattar AH, Elsaid AH, Abdelaleam EA, Abdelkader HK, Ibrahim HM, et al. Repurposing liraglutide to the management of DSS-induced colitis: a potential for promoting autophagy. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(12):17173-17185. doi:10.1007/s00210-025-04339-w
BibTeX
@article{Saadoun2025,
author = {Saadoun, Ahmed Atef and Abdelsattar, Alia Hamed and Elsaid, Amro Hatem and Abdelaleam, Eslam Abdelaziz and Abdelkader, Hazem Khaled and Ibrahim, Hend Mohamed and Saad, Merna Sabri and Ellawi, Moumen Said and Elsaid, Rana Elshahawi and Maghrabia, Aya and Ibrahim, Dina and Ramadan, Nehal M},
title = {Repurposing liraglutide to the management of DSS-induced colitis: a potential for promoting autophagy},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {12},
pages = {17173--17185},
doi = {10.1007/s00210-025-04339-w}
}
EUVIMED